Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1815

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7A
Chunk 1815
---
 individuals serving as our principal executive officer or acting in a similar capacity
during the last completed fiscal year (“PEO”), regardless of compensation level, two most highly compensated executive officers
other than the PEO who were serving as executive officers at the end of the last completed fiscal year, and up to two additional individuals
for whom disclosure would have been provided pursuant to paragraph (m)(2)(ii) of Item 402 of Regulation S-K but for the fact that the
individual was not serving as an executive officer of the smaller reporting company at the end of the last completed fiscal year (each
a “Named Executive Officer”).

67

Summary Compensation Table 

    Name and Principal Position 
    Year  
    Base
    Salary ($)(1)  
    Cash Bonus ($)  
    Stock Bonus ($)  
    Option
    Award ($)(2)  
    Total ($) 
  
    Geoffrey Dow 
     2024  
    $228, 000  
    $20,000  
    $24,175  
    $51,250  
    $323,425 
  
    President and Chief Executive Officer 
     2023  
     125,555  
     -  
     -  
     -  
     125,555 
  
    (Principal Executive Officer) 
     2022  
     54,510  
     -  
     -  
     -  
     54,510 
  
    Tyrone Miller 
     2024  
    $204,000  
    $20,000  
    $19,525  
    $41,000  
    $284,525 
  
    Chief Financial Officer 
     2023  
     135,632  
     -  
     -  
     -  
     135,632 
  
    (Principal Financial and Accounting Officer) 
     2022  
     148,672  
     -  
     -  
     -  
     148,672 
  
    Kristen Landon 
     2024  
    $300,000  
    $113,570  
    $38,125  
    $19,167  
    $470,862 
  
    Chief Commercial Officer 
     2023  
     -  
     -